
July 29, 2024
Positive results from the initial, prospective ADHD clinical trial run by BlinkLab and MCG provides a strong foundation for clinical adoption.
BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing smartphone-based AI powered neurometric tests to aid in the diagnosis of neurodevelopmental conditions, is pleased to announce a major research and clinical partnership with Mental Care Group (MCG) in The Netherlands.
Highlights
- Strategic partnership with the fifth largest outpatient mental health care provider in Europe.
- Partnership formalised following successful outcomes of a pilot study led by Mental Care Group that validated Blinklab’s technology in a clinical setting.
- Initial prospective study in 184 participants showed that children with ADHD have significantly heightened sensory sensitivity, which can be objectively quantified by measuring the rate and amplitude of sound-evoked eyelid responses using the BlinkLab app.
- Partnership will accelerate BlinkLab’s path to European and US regulatory approval for ADHD and clinical adoption. Data collected from the current clinical trial will be used as part of a large global ADHD study conducted by BlinkLab.
- Blinklab and MCG will scale up the rollout and validation of the solution in the coming years to a broader patient group and additional diagnosis.
Smartphone-based digital sensory phenotyping is emerging as a promising aid in the diagnosis of ADHD. BlinkLab has developed an innovative app that administers these tests, using the smartphone’s sensors to capture precise neurometric data. As part of the agreement MCG is anticipating to integrate the BlinkLab app into their processes for ADHD diagnosis. By analysing the nuanced behavioural and physiological responses collected via the app, BlinkLab will aim to identify ADHD characteristics, potentially offering patients a more rapid, accessible and objective assessment method. Through this partnership, MCG will use BlinkLab’s technology to enhance their diagnostic accuracy and efficiency. This collaboration between BlinkLab and MCG exemplifies the potential of our mobile health platform to advance mental health diagnostics worldwide.
About Mental Care Group
Mental Care Group is the largest outpatient mental health care provider in the Netherlands and fifth largest in Europe. With 150 locations it includes a national network of psychologists, psychotherapists and psychiatrists serving over 80,000 patients annually. Leveraging its extensive knowledge and experience in Dutch mental healthcare, MCG focuses on all aged groups. The care offered includes treatments for anxiety disorders, depressive complaints, post-traumatic stress disorders (PTSD), ADHD and autism.
As a pioneer in e-health, MCG provides patients with multiple digital applications, including online enrolment, intake, and an extensive e-health library. Additionally, a segment of their patient base benefits from online or blended treatments. In partnership with BlinkLab, MCG envisions a transformative future where medical technology, AI, and digital applications revolutionize the prediction, diagnosis, and early intervention of healthcare needs. An example of the innovation is the patient portal that MCG developed in-house and went online this week. This collaboration aims to offer innovative treatment and support methods, enhancing patient outcomes and setting new standards in mental healthcare.
European Regulatory Approval and Clinical Adoption
BlinkLab and MCG will work together to obtain regulatory approval for the diagnostic application, and to accelerate the path to clinical adoption and reimbursement. The current study conducted in the Netherlands potentially could be used as part of the global ADHD study with BlinkLab opening additional recruitment and testing.
Click here for the full ASX Release
This article includes content from Blinklab Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
BB1:AU
The Conversation (0)
25 September 2024
BlinkLab Limited
Revolutionising Mental Health Care Through Mobile Solutions
        Revolutionising Mental Health Care Through Mobile Solutions Keep Reading...
01 May
Successful Placement of A$7.66M to Underpin Growth Strategy
        BlinkLab Limited (BB1:AU) has announced Successful Placement of A$7.66M to Underpin Growth StrategyDownload the PDF here. Keep Reading...
29 April
Trading Halt
        BlinkLab Limited (BB1:AU) has announced Trading HaltDownload the PDF here. Keep Reading...
27 April
Quarterly Activities/Appendix 4C Cash Flow Report
        BlinkLab Limited (BB1:AU) has announced Quarterly Activities/Appendix 4C Cash Flow ReportDownload the PDF here. Keep Reading...
31 March
BlinkLab Surpasses Key Milestone in Pivotal U.S. Trial
        BlinkLab Limited (BB1:AU) has announced BlinkLab Surpasses Key Milestone in Pivotal U.S. TrialDownload the PDF here. Keep Reading...
30 March
Trading Halt
        BlinkLab Limited (BB1:AU) has announced Trading HaltDownload the PDF here. Keep Reading...
29 October
ASX AI Stocks: 5 Biggest Companies in 2025
        Artificial intelligence (AI) continues to evolve and advance rapidly, becoming increasingly integrated in the automation of everyday life and a focal point of growth in the technology sector.According to a September 2023 report from IDC on worldwide AI spending, Australia is leading the... Keep Reading...
28 October
Nextech3D.ai Reports Milestone YTD Revenue Growth for AI Matchmaking in 2025 with a 95% Gross Margin
        Nextech3D.ai (CSE:NTAR)(OTCQB:NEXCF)(FSE:1SS), an AI-first technology company specializing in event management, 3D modeling, and spatial computing, is pleased to announce that its Eventdex AI Matchmaking platform has achieved milestone year-to-date revenue growth in 2025 of $100,000 which has a... Keep Reading...
23 October
Chevron Extends Partnership with REM in Major Contract Award
        RemSense Technologies (REM:AU) has announced Chevron Extends Partnership with REM in Major Contract AwardDownload the PDF here. Keep Reading...
17 October
Tech Weekly: Broadcom and OpenAI Sign Deal, AMD and Oracle Announce Partnership
        This week was marked by strong, event-driven volatility across the tech sector. Market moves were shaped by artificial intelligence (AI) infrastructure announcements, semiconductor earnings, signals of macroeconomic stress and escalating tensions between the US and China. Effects of the US... Keep Reading...
16 October
AF2 Capital Corp. Enters into Letter of Intent for Reverse-Takeover Transaction with EverKind Inc.
        AF2 Capital Corp. (TSXV: AF.P) ("AF2" or the "Company") is pleased to announce it has entered into a non-binding letter of intent dated October 14, 2025 (the "LOI") with EverKind Inc. ("EverKind"), an AI-powered emotional wellness platform, which sets forth, in general terms, the basic terms and... Keep Reading...
Latest News
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00







